Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
in loans 154 569 (415) (73.0) Others 1 0 1 n.a. Interest expenses totaled Baht 1,043 million, a decline of 3.6% yoy. Interest expense on debt issued and borrowings reduced by 34.8% from the decline in
lower electricity cost. The average selling price in this quarter was at THB 18,133 per ton, increased 6.5% from the previous quarter, partly due to the increase in market price worldwide, especially in
for the openness of the free trade policy Economic expansion in the developing countries and the continued growth of low-cost airlines, especially in Asia. For the total multi-products fuel
% Million Baht % Selling expenses 22 1% 25 1% (3) (12%) Administrative expenses 191 11% 202 10% (11) (5%) Finance cost 28 2% 32 2% (4) (13%) Income tax expenses 29 2% 30 2% (1) (3%) Selling expenses Selling
3.7% EBITDA Margin 62.1% 61.6% Finance cost 34.9 39.1 (4.2) (10.7%) Income tax expenses 87.8 83.2 4.6 5.5% Profit for the year 345.5 327.1 18.4 5.6% Net Profit to Equity holders of the Company 322.6
. Details of the Company’s rental and services income compared to last year are as follows: (million baht) Quarter 3 rd /2017 Quarter 3 rd /2016 Rental and services income 809 665 Cost 634 445 Gross profit
). The profit from operations before finances cost and taxes (EBIT) was of Bt495.3 million, increasing by Bt27.1 million, or 5.8%(y-o-y). Representing operating profit margin before finances expense and